Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about 28 million people in the United ...
November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
TARRYTOWN, N.Y. and PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use ...
University Hospitals Samaritan Medical Center welcomes two providers who join an expert team to treat diseases like COPD, ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will impact their patients. The ...
When one thinks of who is most likely to develop chronic obstructive pulmonary disease (COPD), a group of progressive, chronic lung diseases caused by inflammation and damage to the lungs, one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results